HomeEDSA • NASDAQ
add
Edesa Biotech Inc
Previous close
$2.33
Year range
$1.55 - $5.59
Market cap
8.08M USD
Avg Volume
3.95M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.90M | 2.22% |
Net income | -1.62M | 3.65% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.86M | -2.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.56M | -63.37% |
Total assets | 4.16M | -46.83% |
Total liabilities | 1.90M | -4.36% |
Total equity | 2.26M | — |
Shares outstanding | 6.94M | — |
Price to book | 6.30 | — |
Return on assets | -118.99% | — |
Return on capital | -222.59% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.62M | 3.65% |
Cash from operations | -1.52M | -7.87% |
Cash from investing | — | — |
Cash from financing | 2.07M | 577.55% |
Net change in cash | 526.18K | 148.11% |
Free cash flow | -845.25K | -0.26% |
About
Founded
2007
Headquarters
Website
Employees
16
